The industry is looking for new ways to manufacture drugs which will save it money and Aprecia thinks it has found it in a method that it has licensed from MIT: 3-D printing. The Langhorne, PA-based company said it is focused on fast-melting pharmaceuticals made for children, the elderly and some special patient groups that have difficulties taking drugs. It expects to go the to the FDA this year with an NDA for its first drug product, which will be in a fast-melting 3-D printed capsule. To that end, the biotech has an agreement with CRO inVentiv Health to provide it commercialization expertise. Story | Announcement